Navigation Links
Protein-coated dental implants could improve bone regeneration

Titanium dental implants coated with proteins that induce bone formation may be a key advancement in treating tooth loss due to gum disease, researchers say.

In laboratory tests, MCG researchers applied a protein onto implants that directs endogenous stem cells to become bone-forming cells. The result was a nearly complete regeneration of lost tissue, says Dr. Ulf Wikesjö, a professor of periodontics in MCG's School of Dentistry.

Loss of teeth and bone is a common and devastating result of gum disease.

Dr. Wikesjö, who came to MCG this year from Temple University in Philadelphia, is researching wound-healing and tissue regeneration with a $1.4 million grant from Nobel Biocare, a leading manufacturer of dental implants and equipment.

Finding the key to improved regeneration is like piecing together a puzzle, Dr. Wikesjö says.

"For the past 20 years, there has been a quest to regenerate tissues around teeth that are lost due to periodontal disease," he says. "I've looked at multiple approaches to achieve regeneration, including bone grafts, root conditioning and membrane devices for directed tissue growth, all resulting in some regeneration. Where we had to look was at the commonalities among these treatments."

Dr. Wikesjö and his colleagues found that any regeneration requires two characteristics: a stable wound and space for the regenerated tissue to grow during the initial stages of healing.

"If these components are in place, regeneration of the tissues around the tooth may occur within a week or two," he says. "After that, it's a matter of the wound maturing ?going through the various stages of healing that we're already familiar with."

By experimenting with treatments and discerning their effect on healing bone defects, they found some ?including some in use today ?that actually hinder tissue regeneration.

"Some biomaterials like hydroxyapatite particles, which are chemically similar to the mineral component of bone, may actually interfere with regeneration," Dr. Wikesjö says. "They may not resorb quickly enough and may block the space for new tissue to grow into."

The experiments helped researchers narrow down possible treatments to the use of proteins that directed stem cells to become bone-forming cells. Those proteins ?called bone morpheonetic proteins ?have already shown promise as a regeneration therapy for craniofacial reconstruction.

"None of us had any idea at the time how or if those proteins could be useful in treating tooth loss," Dr. Wikesjö says.

To find out, researchers placed the proteins around teeth and implants in animal models.

Around teeth, the bone-forming cells grew into existing bone and eventually morphed into bone themselves. However, the root of the tooth was destroyed by the replacement bone. That process impeded regeneration of other essential tissues around the tooth.

Applying the protein to implants proved more beneficial.

"There was almost complete regeneration," he says. "The generated bone bonded with the implant's surface and, eventually, existing bone in the gums. That allowed for the regeneration of gum tissues."

The next step is clinical trials of an implant coated with the proteins, which Dr. Wikesjö hopes to start this summer.

"There are still things we need to learn. In some cases, the protein may rapidly release from the implant, and other times, there appears to be a more gradual release," Dr. Wikesjö says. "We need to find out what factors cause that. In the end, we may not need to use much protein to make the implant effective. Those are things we're looking at now."


Source:Medical College of Georgia

Related biology news :

1. Oldest cranial, dental and postcranial fossils of early modern European humans confirmed
2. Give thanks for the cranberry, say dental researchers
3. Scientists re-grow dental enamel from cultured cells
4. Bacteria from patients dental plaque causes ventilator-associated pneumonia
5. Using dental X-rays to detect osteoporosis
6. Engineers improve plastics potential for use in implants by linking it to biological material
7. Innovative coating could give medical implants a longer life
8. Sooner is better with cochlear implants, Stanford scientist shows
9. Breast implants not associated with cancer risk, study reports
10. With cochlear implants, earlier use leads to better speech
11. Nanotechnology being used to improve biocompatibility of human prosthetics and implants
Post Your Comments:

(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... June 27, 2016  Sequenom, Inc. (NASDAQ: ... healthier lives through the development of innovative products and ... the United States denied its petition ... claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 Patent") ... established by the Supreme Court,s Mayo Collaborative Services v. ...
(Date:6/27/2016)... Chapel Hill, N.C. (PRWEB) , ... June 27, ... ... of U.S. commercial operations for Amgen, will join the faculty of the ... will serve as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... Wausau, WI (PRWEB) , ... June 23, 2016 ... ... probiotic supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, ... supplements for over 35 years, is proud to add Target to its list ...
Breaking Biology Technology: